SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Vascular Biogenics Ltd. (VBLT)

VBLT RSS Feed 		Add VBLT Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board: 
Last Post: 5/28/2017 8:31:23 AM - Followers: 37 - Board type: Free - Posts Today: 0

Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its clinical pipeline is based on two platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti-inflammatory program. Its lead product candidate from its oncology program, VB-111, is a gene-based biologic that is initially developing for recurrent glioblastoma (rGBM), an aggressive form of brain cancer. The Company has also received orphan drug designation in both the United States and Europe. The Company’s oncology program is based on its Vascular Targeting System (VTS), platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. http://www.vblrx.com
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VBLT
Current Price
Volume:
Bid Ask Day's Range
VBLT Detailed Quote
VBLT News: VBL Therapeutics Announces First Quarter 2017 Financial Results 05/15/2017 07:15:00 AM
VBLT News: Report of Foreign Issuer (6-k) 05/15/2017 07:01:52 AM
VBLT News: VBL Therapeutics Presents Data on VB-111 in Combination with Checkpoint Inhibitor at the 20th Annual ASGCT Meeting 05/11/2017 07:00:00 AM
VBLT News: VBL Therapeutics to Report First Quarter 2017 Results on May 15 05/03/2017 08:00:00 AM
VBLT News: VBL Therapeutics Announces Upcoming Presentations on VB-111 at the ASCO and ASGCT 2017 Conferences 04/25/2017 07:00:00 AM
PostSubject
#988   Dropout calculations ? I remember I read somewhere Oren1976 05/28/17 08:31:23 AM
#987   MIXiii Biomed 2017 Program gr8db8 05/23/17 12:45:32 PM
#986   Talk about "a rock and hard place" ... gr8db8 05/21/17 06:42:16 PM
#985   Ok Oren, I see what you are trying wcopeland 05/21/17 05:59:23 PM
#984   Even if we take the average number 24.6% Oren1976 05/21/17 02:06:32 PM
#983   There is a connection between survival rate and Oren1976 05/21/17 01:49:38 PM
#982   Take the data of less than 10% chance Oren1976 05/21/17 01:36:39 PM
#981   Quick response. Sorry will explain better later. GBM wcopeland 05/21/17 01:34:27 PM
#980   In general what i mean to say the Oren1976 05/21/17 01:31:03 PM
#979   I m afraid you didn't get my point. Oren1976 05/21/17 01:24:41 PM
#978   And we don't talk about small sample. Small Oren1976 05/21/17 01:01:19 PM
#977   I think you may be conflating "survival rate wcopeland 05/21/17 12:55:15 PM
#976   I cant even think of a possibility that Oren1976 05/21/17 12:45:08 PM
#975   I think you brought these numbers from clinical Oren1976 05/21/17 12:17:08 PM
#974   Oren, there is no point in chastising him. wcopeland 05/21/17 10:32:50 AM
#973   And just remember one of the reasons trump Oren1976 05/21/17 02:37:36 AM
#972   I think u made a mistake selling vblt. Oren1976 05/21/17 01:42:10 AM
#971   Completely agree with Value. David, it would be wcopeland 05/21/17 01:12:10 AM
#970   davidal66. This is your board and your always Valueinvestor12 05/21/17 12:05:51 AM
#969   Even though I'm out, I still am highly davidal66 05/20/17 11:23:02 PM
#968   I m not saying vbl is a charity Oren1976 05/20/17 10:21:14 PM
#967   Thanks, value. That does further confirm the pricing. gr8db8 05/20/17 07:23:47 PM
#966   Oren, I leave the pricing to the market. gr8db8 05/20/17 07:22:23 PM
#965   gr8db8 This is from Seeking Alpha: Valueinvestor12 05/20/17 06:34:54 PM
#964   sorry just in regards to you selling your raptors1994 05/20/17 06:32:29 PM
#963   If they are smart they charge only 50000 Oren1976 05/20/17 06:22:51 PM
#962   Exactly. I feel the same way. gr8db8 05/20/17 04:48:33 PM
#961   Also, @value. I think you have to make wcopeland 05/20/17 11:43:12 AM
#960   I am still here too, and I will wcopeland 05/20/17 11:35:31 AM
#959   That was my hunch. If you were given davidal66 05/20/17 01:09:45 AM
#958   The original prediction of company to 92 events Oren1976 05/20/17 01:09:21 AM
#957   Yes. The person may have reacted in irrational Oren1976 05/20/17 01:04:16 AM
#956   I'm not sure it was a leak from davidal66 05/20/17 12:56:28 AM
#955   The selloff in tenx was very close to Oren1976 05/20/17 12:48:00 AM
#954   This is very interesting . leak from blinded Oren1976 05/20/17 12:27:33 AM
#953   There was some pre specified number for the davidal66 05/19/17 11:49:10 PM
#952   If no clue. What was the trigger of Oren1976 05/19/17 11:24:29 PM
#951   Trigger of safety analysis. There were 2 so Oren1976 05/19/17 11:15:17 PM
#950   There is no doubt the impression came from Oren1976 05/19/17 09:35:05 PM
#949   I sold my position Monday. I believed holding davidal66 05/19/17 06:48:35 PM
#948   I am staying until at least after the gr8db8 05/19/17 06:01:32 PM
#947   Here you go, Oren: http://www.abstractsonline.com/pp8/#!/4277/presentation/151 gr8db8 05/19/17 05:59:39 PM
#946   Hi gr8db8,davidal66,and wcopeland are you guys still in Valueinvestor12 05/19/17 04:32:40 PM
#945   I search 7 may pr or other sources Oren1976 05/19/17 02:31:21 PM
#944   Surprising the cancer ur thoughts. Do u think Oren1976 05/18/17 01:19:57 PM
#943   All the nice spiders they show u are Oren1976 05/18/17 12:59:36 PM
#942   Indeed, The significance is quite compelling to say memeil26 05/18/17 12:01:37 PM
#941   This is the takeaway from ASCO: gr8db8 05/18/17 11:55:40 AM
#940   You can read it from ASCO's website: memeil26 05/18/17 11:32:24 AM
#939   I said if . hypothetically Oren1976 05/18/17 11:20:09 AM
PostSubject
© 2017 InvestorsHub.Com, Inc.